HAYWARD, Calif., Oct. 11 /PRNewswire/ -- Guava Technologies today launched a new corporate website with an infrastructure focused around its main audiences: Life Scientists, Flow Cytometrists, and Clinicians.
With flow cytometry being an essential tool for cell analysis, Guava Technologies is dedicated to finding innovative ways to make the technology as practical as possible for all life scientists and clinicians who work with cells. This dedication is obvious from the audience-centric organization of the new site, where the main choices on the home page for further investigation are targeted to the unique needs of the company's main markets: Life Science Research (i.e., pharma/biotech, academia/government, clinical research), Flow Cytometry, and Clinical Diagnostics.
While the website does offer traditional navigation, those links are secondary. The site is obviously built around the company's desire to serve its key market segments and stakeholders. According to Lawrence Bruder, CEO, the audience-centric organization was the obvious choice from the beginning: "Those individuals are the reason we are in business; the reason our employees come to work every day," said Mr. Bruder, "so given the importance of our website as a vehicle for two-way communication with them, it just made sense to focus it on their needs."
Guava Technologies encourages everyone interested in flow cytometry or the company to visit the site at http://www.guavatechnologies.com, and to let the company know what it can do to further improve the site based on their needs and interests.
Guava Technologies is a private biotechnology and medical device
company. In 2001, it introduced the first commercial benchtop
microcapillary flow cytometer with easy-to-use, assay-specific reagents and
software. Since then, it has introduced numerous new systems and assays,
always focusing on making flow cytometry more pra
|SOURCE Guava Technologies|
Copyright©2007 PR Newswire.
All rights reserved